Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities
Net income (loss)	$ (85,804,365)	$ (84,618,989)
Adjustments to reconcile Net income (loss) to net cash provided by (used in) operating activities
Depreciation and amortization	2,850,502	3,543,104
Provision for losses on accounts receivable	61,056,089	76,346,104
Gain (Loss) on disposal of property, plant and equipment	1,584	33,923
Amortization of debt discount		41,814
Inventories impairment	30,711,331
Change in fair value of derivative liability		(17,782)
Changes in operating assets
Accounts receivable	(72,590,519)	(103,436,382)
Amount due from related parties	(162,868)
Other current assets	(714,599)	(681,319)
Inventories	11,171,731	95,744,236
Advances to suppliers	36,166,189	(30,473,093)
Other assets	1,512,648	1,414,043
Changes in operating liabilities
Accounts payable	3,084,590	1,906,246
Customer deposits	(539,919)	1,414,707
Tax payables	952,179	(663,905)
Accrued expenses and other payables	1,720,890	744,750
Interest payable		25,659
Net cash provided by (used in) operating activities	(10,584,537)	(38,676,884)
Cash flows from investing activities
Purchase of plant, property, and equipment	(263,711)	(66,210)
Change in construction in process	(205,679)
Net cash provided by (used in) investing activities	(469,390)	(66,210)
Cash flows from financing activities
Proceeds from the sale of common stock		10,252,000
Proceeds from loans	305,200	282,200
Advance from related party	50,000	600,000
Net cash provided by (used in) financing activities	355,200	11,134,200
Effect of exchange rate change on cash and cash equivalents	3,839,537	(3,339,772)
Net increase in cash and cash equivalents	(6,859,191)	(30,948,665)
Cash and cash equivalents, beginning balance	11,934,778	72,259,804
Cash and cash equivalents, ending balance	5,075,587	41,311,138
Supplement disclosure of cash flow information
Interest expense paid	181,269	215,195
Income taxes paid	$ 283,618	$ 2,802,117